Integra LifeSciences Holdings Corporation
IART
$17.46
$0.392.26%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 6.85% | -9.89% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.85% | -9.89% | |||
| Cost of Revenue | 13.21% | -13.86% | |||
| Gross Profit | 2.30% | -6.82% | |||
| SG&A Expenses | 1.25% | -1.64% | |||
| Depreciation & Amortization | -0.16% | 0.21% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.79% | -7.80% | |||
| Operating Income | -1.22% | -24.61% | |||
| Income Before Tax | 296.93% | -155.89% | |||
| Income Tax Expenses | -88.13% | -63.29% | |||
| Earnings from Continuing Operations | 197.08% | -170.95% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 197.08% | -170.95% | |||
| EBIT | -1.22% | -24.61% | |||
| EBITDA | -1.00% | -14.39% | |||
| EPS Basic | 196.67% | -170.27% | |||
| Normalized Basic EPS | -4.51% | -17.41% | |||
| EPS Diluted | 196.67% | -160.87% | |||
| Normalized Diluted EPS | -5.56% | -17.41% | |||
| Average Basic Shares Outstanding | 0.44% | 0.23% | |||
| Average Diluted Shares Outstanding | 1.58% | 0.23% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||